Callable Multi Barrier Reverse Convertible

Symbol: XCHLTQ
ISIN: CH1265332606
Issuer:
Leonteq Securities
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 102.57
Diff. absolute / % 0.01 +0.01%

Determined prices

Last Price 101.77 Volume 5,000
Time 09:16:59 Date 02/05/2024

More Product Information

Core Data

Name Callable Multi Barrier Reverse Convertible
ISIN CH1265332606
Valor 126533260
Symbol XCHLTQ
Quotation in percent Yes
Coupon p.a. 12.00%
Coupon Premium 8.77%
Coupon Yield 3.23%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency Euro
First Trading Date 09/06/2023
Date of maturity 09/06/2025
Last trading day 02/06/2025
Settlement Type Path-dependent
IRS 871m Not applicable
Currency safeguarded No
Pricing Dirty
Issuer Leonteq Securities

Key data

Ask Price (basis for calculation) 103.3900
Maximum yield 11.26%
Maximum yield p.a. 10.59%
Sideways yield 11.26%
Sideways yield p.a. 10.59%

market maker quality Date: 16/05/2024

Average Spread 0.80%
Last Best Bid Price 102.54 %
Last Best Ask Price 103.36 %
Last Best Bid Volume 250,000
Last Best Ask Volume 250,000
Average Buy Volume 250,000
Average Sell Volume 250,000
Average Buy Value 256,374 EUR
Average Sell Value 258,424 EUR
Spreads Availability Ratio 100.00%
Quote Availability 100.00%

Underlyings

Name AXA S.A. Sanofi S.A. Société Générale S.A.
ISIN FR0000120628 FR0000120578 FR0000130809
Price 33.685 EUR 89.85 EUR 27.70 EUR
Date 19/05/24 19:03 19/05/24 19:03 19/05/24 19:03
Cap 27.255 EUR 94.98 EUR 22.61 EUR
Distance to Cap 6.295 -4.74 4.655
Distance to Cap in % 18.76% -5.25% 17.07%
Is Cap Level reached No No No
Barrier 13.628 EUR 47.49 EUR 11.31 EUR
Distance to Barrier 19.922 42.75 15.955
Distance to Barrier in % 59.38% 47.37% 58.52%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.